InvestorsHub Logo
Followers 164
Posts 12802
Boards Moderated 1
Alias Born 01/26/2016

Re: koman post# 56066

Saturday, 03/05/2016 9:44:04 AM

Saturday, March 05, 2016 9:44:04 AM

Post# of 693162
koman,

Thanks for the reply. I do appreciate your point of view and have considered the evidence you and others have pointed to and the obvious lack of clarity given by the company. I do also know about the grant income which was set aside for trial participants. The HE reimbursement issue is separate from that based on the conditions given for its use. You should be aware of that if you are not.

I have yet to hear an explanation from any negative poster for the importance of CXCR4. Would you care to take a stab at it? Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News